Incidence and Risk Factors of C. Trachomatis and N. Gonorrhoeae Among Young Women from the Western Cape, South Africa: The EVRI Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2021 May 3

PMID 33939747

Citations 9

Authors

Vita W Jongen

Maarten F Schim van der Loeff

Matthys H Botha

Staci L Sudenga

Martha E Abrahamsen

Anna R Giuliano

Affiliations

Soon will be listed here.

Abstract

Objective: Young women in South Africa are highly affected by sexually transmitted infections (STI), like C. trachomatis (CT) and N. gonorrhoeae (NG). We aimed to estimate the incidence of CT and NG, and its determinants, among young women from the Western Cape, South Africa, participating in an HPV vaccine trial (the EVRI study).

Methods: HIV-negative women aged 16-24 years were enrolled between October 2012 and July 2013. At enrolment and month 6 participants were screened for CT and NG (Anyplex CT/NG real-time detection method). A questionnaire on demographic and sexual history characteristics was completed at enrolment and month 7. Treatment for CT and/or NG was offered to infected participants. Incidence rates (IR) of CT and NG were estimated. Determinants of incident CT and NG infections were assessed using Poisson regression.

Results: 365 women were tested for CT and/or NG at least twice. Prevalence of CT and NG at baseline was 33.7% and 10.4%, respectively. Prevalence of co-infection with CT and NG was 7.1%. During 113.3 person-years (py), 48 incident CT infections were diagnosed (IR = 42.4 per 100 py, 95% confidence interval (CI) 31.9-56.2). Twenty-nine incident NG were diagnosed during 139.3 py (IR = 20.8 per 100 py, 95%CI 14.5-29.9). Prevalent CT infection at baseline was associated with incident CT (adjusted incidence rate ratio (aIRR) 5.8, 95%CI 3.0-11.23. More than three lifetime sex partners increased the risk for incident NG (3-4 partners aIRR = 7.3, 95%CI 2.1-26.0; ≥5 partners aIRR = 4.3, 95%CI 1.1-17.5).

Conclusions: The IR of bacterial STIs among young women in the Western Cape is very high. Besides being previously infected and a higher lifetime number of sex partners, no other risk factors were found for CT and NG, suggesting that the majority of these women were at risk. This indicates the need for intensified prevention of STIs as well as screening and treatment programs to increase sexual health in this region.

Citing Articles

Enhanced and Sexually Transmitted Infections and Associated Risk Factors in Fiji Following the Coronavirus Disease 2019 Pandemic.

Auchus I, Brown J, Kama M, Vargo S, Devi R, Singh J Open Forum Infect Dis. 2025; 12(3):ofaf101.

PMID: 40046883 PMC: 11881064. DOI: 10.1093/ofid/ofaf101.

When Bacteria and Viruses Collide: A Tale of and Sexually Transmitted Viruses.

Ghasemian E, Harding-Esch E, Mabey D, Holland M Viruses. 2023; 15(9).

PMID: 37766360 PMC: 10536055. DOI: 10.3390/v15091954.

HIV/STD prevalence and test uptake among african in Guangzhou, China: an analysis of data from hospital-based surveillance.

Xiong M, Yang M, Zhao P, Huang S, Wang C BMC Infect Dis. 2023; 23(1):597.

PMID: 37704962 PMC: 10498562. DOI: 10.1186/s12879-023-08590-5.

Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa.

Rousseau E, Wu L, Heffron R, Baeten J, Celum C, Travill D Front Reprod Health. 2023; 5:1073103.

PMID: 37325240 PMC: 10266091. DOI: 10.3389/frph.2023.1073103.

Usability of a novel lateral flow assay for the point-of-care detection of Neisseria gonorrhoeae: A qualitative time-series assessment among healthcare workers in South Africa.

de Vos L, Daniels J, Gebengu A, Mazzola L, Gleeson B, Piton J PLoS One. 2023; 18(6):e0286666.

PMID: 37267319 PMC: 10237465. DOI: 10.1371/journal.pone.0286666.

References

Johnson L, Lewis D . The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. 2008; 35(11):946-59. DOI: 10.1097/OLQ.0b013e3181812d15. View

Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad L . Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019; 97(8):548-562P. PMC: 6653813. DOI: 10.2471/BLT.18.228486. View

Guffey M, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E . HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sex Transm Infect. 2014; 90(5):363-9. PMC: 4278566. DOI: 10.1136/sextrans-2014-051537. View

Moodley D, Moodley P, Sebitloane M, Soowamber D, McNaughton-Reyes H, Groves A . High prevalence and incidence of asymptomatic sexually transmitted infections during pregnancy and postdelivery in KwaZulu Natal, South Africa. Sex Transm Dis. 2014; 42(1):43-7. DOI: 10.1097/OLQ.0000000000000219. View

Haggerty C, Gottlieb S, Taylor B, Low N, Xu F, Ness R . Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010; 201 Suppl 2:S134-55. DOI: 10.1086/652395. View

Dubbink J, Verweij S, Struthers H, Ouburg S, McIntyre J, Morre S . Genital Chlamydia trachomatis and Neisseria gonorrhoeae infections among women in sub-Saharan Africa: A structured review. Int J STD AIDS. 2018; 29(8):806-824. DOI: 10.1177/0956462418758224. View

Venkatesh K, van der Straten A, Mayer K, Blanchard K, Ramjee G, Lurie M . African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis. 2011; 38(6):562-70. DOI: 10.1097/OLQ.0b013e31820a8c2c. View

Kularatne R, Niit R, Rowley J, Kufa-Chakezha T, Peters R, Taylor M . Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017. PLoS One. 2018; 13(10):e0205863. PMC: 6188893. DOI: 10.1371/journal.pone.0205863. View

Ramjee G, Dassaye R, Reddy T, Wand H . Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials. J Infect Dis. 2018; 218(11):1759-1766. PMC: 7191892. DOI: 10.1093/infdis/jiy388. View

10.

de Oliveira T, Kharsany A, Graf T, Cawood C, Khanyile D, Grobler A . Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. Lancet HIV. 2016; 4(1):e41-e50. PMC: 5479933. DOI: 10.1016/S2352-3018(16)30186-2. View

11.

Houle B, Mojola S, Angotti N, Schatz E, Gomez-Olive F, Clark S . Sexual behavior and HIV risk across the life course in rural South Africa: trends and comparisons. AIDS Care. 2018; 30(11):1435-1443. PMC: 6150786. DOI: 10.1080/09540121.2018.1468008. View

12.

Kharsany A, McKinnon L, Lewis L, Cawood C, Khanyile D, Maseko D . Population prevalence of sexually transmitted infections in a high HIV burden district in KwaZulu-Natal, South Africa: Implications for HIV epidemic control. Int J Infect Dis. 2020; 98:130-137. PMC: 7484252. DOI: 10.1016/j.ijid.2020.06.046. View

13.

Kaida A, Dietrich J, Laher F, Beksinska M, Jaggernath M, Bardsley M . A high burden of asymptomatic genital tract infections undermines the syndromic management approach among adolescents and young adults in South Africa: implications for HIV prevention efforts. BMC Infect Dis. 2018; 18(1):499. PMC: 6171143. DOI: 10.1186/s12879-018-3380-6. View

14.

Zakher B, Cantor A, Pappas M, Daeges M, Nelson H . Screening for gonorrhea and Chlamydia: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014; 161(12):884-93. DOI: 10.7326/M14-1022. View

15.

Pettifor A, Delany S, Kleinschmidt I, Miller W, Atashili J, Rees H . Use of injectable progestin contraception and risk of STI among South African women. Contraception. 2009; 80(6):555-60. PMC: 2902790. DOI: 10.1016/j.contraception.2009.06.007. View

16.

Detels R, Green A, Klausner J, Katzenstein D, Gaydos C, Handsfield H . The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis. 2012; 38(6):503-9. PMC: 3408314. View

17.

Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C . Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009; 36(4):199-206. DOI: 10.1097/OLQ.0b013e318191ba01. View

18.

Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C . Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012; 206(1):6-14. PMC: 3490689. DOI: 10.1093/infdis/jis298. View

19.

Chirenje Z, Gundacker H, Richardson B, Rabe L, Gaffoor Z, Nair G . Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003). Sex Transm Dis. 2017; 44(3):135-140. PMC: 5535309. DOI: 10.1097/OLQ.0000000000000568. View

20.

Cohen M, Council O, Chen J . Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc. 2019; 22 Suppl 6:e25355. PMC: 6715951. DOI: 10.1002/jia2.25355. View